Abstract
Since radiation therapy treatment technology has improved with time, we investigated the impact of radiation, both thoracic (TRT) and prophylactic cranial (PCI), on survival (OS) for patients with limited-stage small cell lung cancer (LS-SCLC). We also investigated the toxicity of these treatments by examining secondary endpoints of mortality due to cardiac disease (CD) or stroke (CVA).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
